Analyst Ratings for Sinovac Biotech (SVA) [Buys]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/20/2014 | Morgan Stanley | N/A | Upgrade | Overweight (Equalweight) |
N/A (N/A) |
6.89 (6.47) |
-6.1% | Details |
8/15/2013 | Aegis Capital » Updated 3/20/2014 |
N/A | Upgrade | Buy (Hold) |
7.00 (N/A) |
4.57 (6.47) |
41.58% | Details |